全文获取类型
收费全文 | 12477篇 |
免费 | 625篇 |
国内免费 | 150篇 |
专业分类
耳鼻咽喉 | 70篇 |
儿科学 | 452篇 |
妇产科学 | 283篇 |
基础医学 | 828篇 |
口腔科学 | 431篇 |
临床医学 | 1051篇 |
内科学 | 2741篇 |
皮肤病学 | 218篇 |
神经病学 | 525篇 |
特种医学 | 280篇 |
外科学 | 1526篇 |
综合类 | 521篇 |
现状与发展 | 1篇 |
一般理论 | 12篇 |
预防医学 | 1886篇 |
眼科学 | 160篇 |
药学 | 778篇 |
中国医学 | 845篇 |
肿瘤学 | 644篇 |
出版年
2024年 | 12篇 |
2023年 | 288篇 |
2022年 | 406篇 |
2021年 | 655篇 |
2020年 | 512篇 |
2019年 | 1006篇 |
2018年 | 960篇 |
2017年 | 620篇 |
2016年 | 387篇 |
2015年 | 360篇 |
2014年 | 697篇 |
2013年 | 1057篇 |
2012年 | 443篇 |
2011年 | 541篇 |
2010年 | 415篇 |
2009年 | 467篇 |
2008年 | 494篇 |
2007年 | 434篇 |
2006年 | 303篇 |
2005年 | 253篇 |
2004年 | 210篇 |
2003年 | 199篇 |
2002年 | 165篇 |
2001年 | 171篇 |
2000年 | 134篇 |
1999年 | 90篇 |
1998年 | 67篇 |
1997年 | 70篇 |
1996年 | 47篇 |
1995年 | 31篇 |
1994年 | 41篇 |
1993年 | 29篇 |
1992年 | 20篇 |
1991年 | 16篇 |
1990年 | 20篇 |
1988年 | 19篇 |
1987年 | 17篇 |
1985年 | 141篇 |
1984年 | 185篇 |
1983年 | 145篇 |
1982年 | 178篇 |
1981年 | 168篇 |
1980年 | 146篇 |
1979年 | 116篇 |
1978年 | 118篇 |
1977年 | 75篇 |
1976年 | 109篇 |
1975年 | 61篇 |
1974年 | 66篇 |
1973年 | 70篇 |
排序方式: 共有10000条查询结果,搜索用时 93 毫秒
81.
82.
83.
目的 通过挖掘整理含丹参-当归的方剂,利用统计软件系统分析其用药规律。方法 检索筛选《中医方剂大辞典》中含丹参-当归药对的方剂,利用Excel软件分析中药使用频次、频率及丹参-当归配伍特征和主治中医病证频次,运用SPSS Modeler 18.0软件关联规则Apriori算法进行数据挖掘。结果 通过统计共筛选出含丹参-当归药对的方剂390首,频次统计分析发现涉及中药504味,使用频次≥60的中药共22味,除丹参、当归外,核心高频药物为川芎、甘草、白芍、肉桂、地黄、牛膝6味。通过组方规律分析得到常用中药组合有丹参-当归-川芎、丹参-当归-甘草、丹参-当归-白芍。主治病证涉及105种,频次≥10的中医病证10种,以瘀血疼痛病症、妇科病症为主。通过网络可视化得到治疗月经病的核心中药组合为丹参-当归-川芎-白芍-香附,治疗痹证的核心中药组合为丹参-当归-川芎-肉桂,治疗虚劳病核心中药组合为丹参-当归-牛膝-肉桂-防风。结论 与丹参-当归配伍的高频中药为白芍、川芎、肉桂等,优势病证为月经病、痹证和虚劳病,揭示了丹参-当归药对的用药规律,为该药对在临床合理用药及深入研究与开发提供科学依据。 相似文献
84.
骨质疏松症(osteoporosis,OP)是一种以骨密度降低、骨骼微结构改变和骨质脆弱增加为特征的骨骼疾病。由于老龄化问题的逐渐加重,OP的发病率在全球范围内迅速增加。中药在预防和治疗OP中表现出极好的前景和临床效果,然而传统动物模型具有耗时长、费用昂贵、无法准确概括骨疾病复杂性等缺点,很大程度上限制了临床前OP疾病的研究进程。而斑马鱼模型可有效模拟人类骨质减少和OP表型,通过对斑马鱼模型在治疗OP研究中的优势和适用性及该模型在中药抗OP的研究进展进行综述,为斑马鱼模型的广泛使用及中药新药研发提供参考。 相似文献
85.
甲状腺未分化癌(ATC)发病率低、预后差,为指导临床医生和研究人员对其进行规范化诊断和治疗管理,美国甲状腺学会于2012年制定了第1版《甲状腺未分化癌病人管理指南》。随着分子检测和靶向治疗结果的不断积累,2021年美国甲状腺学会对该指南进行了更新。新版指南强调了BRAFV600E分子检测在诊断及靶向治疗中的作用,增加了靶向治疗的内容,对晚期无法切除的 ATC病人更加推荐靶向治疗,而化疗则被更多的用于过渡性治疗和最终治疗。此外,新版指南也对病人的人文关怀进行了丰富和完善。 相似文献
86.
Emrah Caliskan Salih Suha Koparal Volkan Igdir Emre Alp Ozgur Dogan 《Foot and Ankle Surgery》2021,27(4):457-462
BackgroundThe measurement of plantar fascia thickness with ultrasonography can be used for both for diagnosis and as a response-to-treatment parameter in plantar fasciitis. Furthermore, with the recent studies, red cell distribution width may be used as an inflammatory marker. Aim of this study is to investigate the association of red cell distribution width and ultrasonography on diagnosis and monitoring of treatment in patients with plantar fasciitis.MethodsClinically diagnosed 102 patients with plantar fasciitis between the dates January 2016 to July 2018 were analysed. Hemogram, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and plantar fascial ultrasonography were obtained on initial evaluation and in 1 month, 2 months and 3 months of the standard nonoperative treatment; American Orthopaedic Foot & Ankle Hindfoot Score (AOFAS) and Visual Analog Scale (VAS) scores were recorded. Posthoc and multivariate logistic regression analysis were used for statistical analysis on SPSS 21.0.ResultsRed cell distribution width was correlated with plantar fascia thickness by the end of the 1 month (r = 0.26, P = .013). Female sex, BMI over 30 kg/m2, higher red cell distribution width and higher plantar fascia thickness were associated with plantar fasciitis on initial evaluation. Higher red cell distribution width together with higher plantar fascia thickness were also found to be a risk factor for both on initial evaluation and 1 month after treatment in plantar fasciitis.ConclusionThis study shows that association of red cell distribution width and plantar fascia thickness can be not only a diagnostic predictor but also an indicator of treatment response in plantar fasciitis.Level of clinical evidenceLevel IV 相似文献
87.
Olubukola O. Nafiu Christian Mpody Marc P. Michalsky Joseph D. Tobias 《Surgery for obesity and related diseases》2021,17(7):1249-1255
BackgroundRacial disparities in postsurgical complications are often presumed to be due to a higher preoperative co-morbidity burden among patients of black race, although being relatively healthy is not a prerequisite for a complication-free postoperative course.ObjectivesTo examine the association of race with short-term postbariatric surgery complications in seemingly healthy patients.SettingsMetabolic and Bariatric Surgery Accreditation and Quality Improvement Program database (2015–2018).MethodsWe studied a relatively healthy (American Society of Anesthesiologists physical status 1 or 2), propensity score–matched cohort of adult non-Hispanic black and non-Hispanic white bariatric surgery patients. We compared the risk-adjusted incidences of postoperative complications, serious adverse events, and measures of postoperative resource utilization across racial groups.ResultsWe identified 44,090 matched pairs of relatively healthy black and white bariatric surgery patients. Patients of black race were 72% more likely than those of white race to develop 1 or more postoperative complications (.7% versus .4%, respectively; odds ratio [OR], 1.72; 95% confidence interval [CI], 1.32–2.24; P < .01). Measures of postbariatric resource utilization were significantly higher in patients of black race than those of white race, including unplanned reoperations (1.3% versus 1.0%, respectively; OR, 1.28; 95% CI, 1.07–1.52; P = .01), unplanned readmissions (4.5% versus 3.0%, respectively; OR, 1.53; 95% CI, 1.38–1.69; P < .01), unplanned interventions (1.6% versus 1.2%, respectively; OR, 1.36; 95% CI, 1.16–1.60; P < .01), and extended hospital lengths of stay (51.2% versus 42.7%, respectively; OR, 1.41; 95% CI, 1.36–1.46; P < .01).ConclusionEven among relatively healthy patients, race appears to be an important determinant of postbariatric surgery complications and resource utilization. Research and interventions aimed at narrowing the racial disparities in bariatric surgery outcomes may need to broaden the focus beyond the racial variation in the preoperative co-morbidity burden. 相似文献
88.
Katelyn J. Yoo Soonman Kwon Yoonjung Choi David M. Bishai 《Health policy (Amsterdam, Netherlands)》2021,125(5):568-576
South Korea’s COVID-19 control strategy has been widely emulated. Korea’s ability to rapidly achieve disease control in early 2020 without a “Great Lockdown” despite its proximity to China and high population density make its achievement particularly intriguing. This paper helps explain Korea’s pre-existing capabilities which enabled the rapid and effective implementation of its COVID-19 control strategies. A systematic assessment across multiple domains demonstrates that South Korea’s advantages in controlling its epidemic are owed tremendously to legal and organizational reforms enacted after the MERS outbreak in 2015. Successful implementation of the Korean strategy required more than just a set of actions, measures and policies. It relied on a pre-existing legal framework, financing arrangements, governance and a workforce experienced in outbreak management. 相似文献
89.
90.
炭药的炮制工艺改进及质量标准初探 总被引:3,自引:0,他引:3
采用加入介质和改变火力的方法改进传统的炭药炮制工艺,用pH值测定法控制炭药质量,通过测定山楂不同炮制工艺所得标准炭品的pH值和酸性物质含量,以及相关的药理实验,来验证改进工艺的可行性。 相似文献